
Importance of PCRF’s ‘BRCAness’ research underlined by drug success
The recent news that the drug olaparib delayed the progress of advanced pancreatic cancer in patients who have faults in the BRCA1 and 2 genes underlines the relevance and importance of a PCRF-funded research project being carried out by Dr Mairéad McNamara from the University of Manchester and The Christie NHS Foundation Trust.